PATENT CLAIM ANALYSIS

Application Number: 15742276
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "255060"]

Abstract:
The invention relates to compounds of Formula I: or the salts thereof, as well as the use thereof in the pharmaceutical, cosmetic or agrofood industry.

Claim (Index 17):
Method according to  claim 16 , wherein the diseases or disorders are selected from atherosclerosis, retinopathy, nephropathy, neuropathy, micro and macroangiopathies, cataract, amyloidosis, rheumatic disorders and varicose and arterial ulcers.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.26087
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15124264', '14349595', '15635454', '13138227', '15259922']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588664209196629
- 35 USC 102 Novelty (BERT): 0.53440571238176
- Combined Prediction Score: 0.7364203500658727
- Mean Citation Score: 293.34071400000005
- Max Citation Score: 309.03735
- Similarity Product: 167.02912024826108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test